186 related articles for article (PubMed ID: 7561976)
1. Flexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: comparison of predicted and experimental conformations of inhibitors of three enzymes.
McMartin C; Bohacek RS
J Comput Aided Mol Des; 1995 Jun; 9(3):237-50. PubMed ID: 7561976
[TBL] [Abstract][Full Text] [Related]
2. QXP: powerful, rapid computer algorithms for structure-based drug design.
McMartin C; Bohacek RS
J Comput Aided Mol Des; 1997 Jul; 11(4):333-44. PubMed ID: 9334900
[TBL] [Abstract][Full Text] [Related]
3. Different approaches toward an automatic structural alignment of drug molecules: applications to sterol mimics, thrombin and thermolysin inhibitors.
Klebe G; Mietzner T; Weber F
J Comput Aided Mol Des; 1994 Dec; 8(6):751-78. PubMed ID: 7738608
[TBL] [Abstract][Full Text] [Related]
4. Structure-based thermodynamic design of peptide ligands: application to peptide inhibitors of the aspartic protease endothiapepsin.
Luque I; Gómez J; Semo N; Freire E
Proteins; 1998 Jan; 30(1):74-85. PubMed ID: 9443342
[TBL] [Abstract][Full Text] [Related]
5. A novel method for the modelling of peptide ligands to their receptors.
Singh J; Saldanha J; Thornton JM
Protein Eng; 1991 Feb; 4(3):251-61. PubMed ID: 1857711
[TBL] [Abstract][Full Text] [Related]
6. Empirical free energy as a target function in docking and design: application to HIV-1 protease inhibitors.
King BL; Vajda S; DeLisi C
FEBS Lett; 1996 Apr; 384(1):87-91. PubMed ID: 8797810
[TBL] [Abstract][Full Text] [Related]
7. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming.
Gehlhaar DK; Verkhivker GM; Rejto PA; Sherman CJ; Fogel DB; Fogel LJ; Freer ST
Chem Biol; 1995 May; 2(5):317-24. PubMed ID: 9383433
[TBL] [Abstract][Full Text] [Related]
8. The local minima method (LMM) of pharmacophore determination: a protocol for predicting the bioactive conformation of small, conformationally flexible molecules.
Demeter DA; Weintraub HJ; Knittel JJ
J Chem Inf Comput Sci; 1998; 38(6):1125-36. PubMed ID: 9845967
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
10. Conformational analysis of TMC114, a novel HIV-1 protease inhibitor.
Nivesanond K; Peeters A; Lamoen D; Van Alsenoy C
J Chem Inf Model; 2008 Jan; 48(1):99-108. PubMed ID: 18173253
[TBL] [Abstract][Full Text] [Related]
11. FLEXS: a method for fast flexible ligand superposition.
Lemmen C; Lengauer T; Klebe G
J Med Chem; 1998 Nov; 41(23):4502-20. PubMed ID: 9804690
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.
Waller CL; Oprea TI; Giolitti A; Marshall GR
J Med Chem; 1993 Dec; 36(26):4152-60. PubMed ID: 8277496
[TBL] [Abstract][Full Text] [Related]
13. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
[TBL] [Abstract][Full Text] [Related]
14. A mean field model of ligand-protein interactions: implications for the structural assessment of human immunodeficiency virus type 1 protease complexes and receptor-specific binding.
Verkhivker GM; Rejto PA
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):60-4. PubMed ID: 8552675
[TBL] [Abstract][Full Text] [Related]
15. Prediction of ligand-receptor binding thermodynamics by free energy force field (FEFF) 3D-QSAR analysis: application to a set of peptidometic renin inhibitors.
Tokarski JS; Hopfinger AJ
J Chem Inf Comput Sci; 1997; 37(4):792-811. PubMed ID: 9254912
[TBL] [Abstract][Full Text] [Related]
16. A semiempirical free energy force field with charge-based desolvation.
Huey R; Morris GM; Olson AJ; Goodsell DS
J Comput Chem; 2007 Apr; 28(6):1145-52. PubMed ID: 17274016
[TBL] [Abstract][Full Text] [Related]
17. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
Taylor RD; Jewsbury PJ; Essex JW
J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
[TBL] [Abstract][Full Text] [Related]
18. Refining the multiple protein structure pharmacophore method: consistency across three independent HIV-1 protease models.
Meagher KL; Lerner MG; Carlson HA
J Med Chem; 2006 Jun; 49(12):3478-84. PubMed ID: 16759090
[TBL] [Abstract][Full Text] [Related]
19. A fast and efficient method to generate biologically relevant conformations.
Klebe G; Mietzner T
J Comput Aided Mol Des; 1994 Oct; 8(5):583-606. PubMed ID: 7876902
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo docking of oligopeptides to proteins.
Caflisch A; Niederer P; Anliker M
Proteins; 1992 Jul; 13(3):223-30. PubMed ID: 1603811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]